Earnings Feed
Start Free
LIXTE BIOTECHNOLOGY HOLDINGS, INC.·4

Jul 2, 4:06 PM ET

Schwartzberg Gil 4

4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Jul 2, 2021

Insider Transaction Report

Form 4
Period: 2021-06-30
LIXTE BIOTECHNOLOGY HOLDINGS, INC.LIXT
Schwartzberg Gil
10% Owner
Transactions
  • Award

    Option to Purchase Common Stock

    2021-06-30+100,000→ 100,000 total
    Exercise: $3.03From: 2021-06-30Exp: 2026-06-30→ Common (100,000 underlying)
Holdings

  • Options to Purchase Common Stock

    Exercise: $3.00From: 2016-01-28Exp: 2024-01-28→ Common (83,333 underlying)
    83,333

  • Options to Purchase Common Stock

    (indirect: By Trust)
    Exercise: $3.00From: 2015-01-28Exp: 2024-01-28→ Common (291,667 underlying)
    291,667

  • Option to Purchase Common Stock

    Exercise: $3.20From: 2021-04-09Exp: 2026-04-01→ Common (250,000 underlying)
    250,000

  • Warrant to Purchase Common Stock

    (indirect: By Trust)
    Exercise: $6.00From: 2018-12-07Exp: 2022-11-30→ Common (83,333 underlying)
    83,333

  • Warrant to Purchase Common Stock

    Exercise: $5.70From: 2020-11-30Exp: 2025-11-30→ Common (105,264 underlying)
    105,264

  • Warrant to Purchase Common Stock

    (indirect: By Trust)
    Exercise: $6.00From: 2018-12-07Exp: 2022-11-30→ Common (83,333 underlying)
    83,333
Footnotes (1)
  • [F1]Effective June 30, 2021, the reporting person was granted stock options to purchase an aggregate of 100,000 shares, vesting in eight equal installments on the last day of each subsequent quarter until fully vested (e.g. vesting to start on September 20, 2021).

Documents

1 file
  • 4
    ownership.xmlPrimary